Stockreport

FDA Approves Bristol-Myers Squibb's Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF price target on Bristol-Myers Squibb to $57 from $51, while maintaining a Neutral rating on the shares. Earlier on December 4, Bristol-Myers Squibb announced that the [Read more]